爱美客：控股子公司REGEN仲裁迎新进展 临时措施决定被撤销

Core Viewpoint - The arbitration case involving REGEN, a subsidiary of Aimeike, has seen a significant development with the Shenzhen International Arbitration Court revoking a previous emergency measure that restricted REGEN's operations regarding the AestheFill product in China [1][2] Group 1: Arbitration Developments - On January 29, REGEN received a decision from the Shenzhen International Arbitration Court that revoked the emergency measures imposed on September 10, 2025, which had restricted REGEN from selling AestheFill products in China and recognized Dato Company as the exclusive distributor [1] - The emergency measures had previously mandated that REGEN could not deny Dato Company's exclusive distribution rights and was required to continue supplying products as per the agreement [1] Group 2: REGEN's Counterclaims - REGEN's counterclaims in the arbitration include requests to terminate Dato Company's exclusive agency rights for AestheFill products in mainland China, to annul the related distribution agreements, and to seek compensation for reasonable expenses incurred during the arbitration process [2] - REGEN asserts that Dato Company has committed serious breaches of contract, justifying the termination of the exclusive agency rights and the annulment of the agreements [2] Group 3: Ongoing Legal Proceedings - The arbitration case is still under review, and the impact on Aimeike's current and future profits remains uncertain, contingent on the final arbitration or enforcement results [2] - REGEN has engaged a professional legal team to actively address the arbitration case and will closely monitor its progress [2]